Monograph
A01AD01 - Epinephrine |
Not porphyrinogenic |
NP |
Rationale
Epinephrine (adrenaline) is an endogenous catecholamine with non-CYP dependent metabolism. There are no data pointing to CYP-interaction.
Chemical description
Endogenous catecholamine.
Therapeutic characteristics
Epinephrine (adrenaline) is a catecholamine used in asthma bronchiale, cardiac arrest, hypersensitivity reactions. Parenterally administered in 0.3-1 mg dose.
Metabolism and pharmacokinetics
Epinephrine (adrenalin) is an endogenous compound. It is very rapidly inactivated by processes which include uptake into adrenergic neurones, diffusion, and enzymatic degradation in the liver and body tissues. Metabolism involves monoamine oxidase (MAO) and catechol-O-methyl transferase (COMT). As a result of enzymatic degradation in the gut and first-pass metabolism in the liver, adrenaline is almost totally inactive when given orally.
IPNet drug reports
Uneventful use reported in 5 patients with acute porphyria, in combination with local anaesthetics.
Similar drugs
References
| # | Citation details | PMID |
|---|---|---|
| * | Scientific articles | |
| 1. | MFM James, RJ Hift. Porphyrias. Br J Anaesth 2000; 85, 143-53.
|
|
| * | Drug reference publications | |
| 2. | Sweetman SC, editor. Martindale: The complete drug reference. Adrenaline. Pharmaceutical Press 2009.
|
|
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Gingi-Pak
© NAPOS 2025